Literature DB >> 3982574

Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.

E A Brown, N Markandu, G A Sagnella, B E Jones, G A MacGregor.   

Abstract

There is increasing evidence that the sodium retention of nephrotic syndrome is directly due to an intrarenal mechanism and not to a low blood volume stimulating the renin-angiotensin-aldosterone system. However the mechanism of the natriuresis that occurs during remission is not known. Patients with nephrotic syndrome were therefore studied during steroid-induced remission. At the onset of natriuresis, blood volume and plasma albumin were low and did not change. Plasma renin activity and plasma aldosterone were initially high and both fell during the natriuresis. At the end of the natriuresis when patients had lost their oedema, plasma renin activity and plasma aldosterone rose to high levels, plasma albumin and blood volume remained low, and yet the patients were no longer retaining sodium and were in sodium balance. These observations suggest that the natriuresis of remission is due to the correction of an intrarenal mechanism causing the sodium retention. This study raises two major unanswered questions. Firstly, when the presumed intrarenal mechanism is corrected, what tells the kidney to excrete large amounts of sodium when the blood volume remains low? Secondly, why do the patients come back into sodium balance when the blood volume is low, and plasma renin activity and plasma aldosterone are elevated?

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3982574     DOI: 10.1159/000183392

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

1.  Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.

Authors:  A Meyrier; P Simon; G Perret; M C Condamin-Meyrier
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-22

Review 2.  The nephrotic syndrome.

Authors:  E A Brown
Journal:  Postgrad Med J       Date:  1985-12       Impact factor: 2.401

Review 3.  Diuretic Resistance.

Authors:  Ewout J Hoorn; David H Ellison
Journal:  Am J Kidney Dis       Date:  2016-11-01       Impact factor: 8.860

Review 4.  Intra- and extrarenal factors of oedema formation in the nephrotic syndrome.

Authors:  T Tulassay; W Rascher; K Schärer
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

5.  Over- or underfill: not all nephrotic states are created equal.

Authors:  Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2013-03-26       Impact factor: 3.714

6.  Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome.

Authors:  P A Sjöström; B G Odlind; B A Beermann; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  Human albumin infusion for treating oedema in people with nephrotic syndrome.

Authors:  Jacqueline J Ho; Azreen S Adnan; Yee Cheng Kueh; Nurul Jannah Ambak; Hans Van Rostenberghe; Fauziah Jummaat
Journal:  Cochrane Database Syst Rev       Date:  2019-07-12

8.  Albumin is an interface between blood plasma and cell membrane, and not just a sponge.

Authors:  Jens van de Wouw; Jaap A Joles
Journal:  Clin Kidney J       Date:  2021-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.